MIPS521|cas:1146188-19-3|西域试剂

MIPS521,99.65%

产品编号：Bellancom-139644| CAS NO：1146188-19-3| 分子式：C₁₉H₁₀ClF₆NOS| 分子量：449.80

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-139644	￥900.00	杭州北京（现货）
Bellancom-139644	￥1400.00	杭州北京（现货）
Bellancom-139644	￥4200.00	杭州北京（现货）
Bellancom-139644	￥6500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

MIPS521

产品介绍

MIPS521 是腺苷受体 (A₁AR) 的正向变构调节剂。MIPS521 还具有较低的 A₁AR 变构亲和力 (pK_B=4.95; K_B=11 μM)。MIPS521 通过调节大鼠脊髓中内源性腺苷水平的升高，在体内表现出减轻疼痛的作用。

生物活性

MIPS521 is a positive allosteric modulator of adenosine A₁ receptor (A₁AR). MIPS521 also has a lower A₁R allosteric affinity (pK_B=4.95; K_B=11 μM). MIPS521 exhibits pain-relieving effects in vivo through modulation of the increased levels of endogenous adenosine.

体外研究

MIPS521 (compound 13o) (3-10 μM) improves the ability of R-PIA to promote A₁AR-mediated ERK1/2 phosphorylation.
MIPS521 (0.3-30 μM; pretreament for 10 min, co-treatment for 30 min) produces a concentration-dependent potentiation of signalling by ADO in an inhibition of cAMP assay (expressed as a percentage of the inhibition of 3 μM forskolin-mediated cAMP) in CHO cells.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

MIPS521 (1-30 μg in 10 μL; intrathecal administration) reverses mechanical hyperalgesia in rats, promoting robust antinociception.
MIPS521 (10 μg in 10 μL; intrathecal administration) significantly reduces spontaneous pain in a conditioned place preference model.
MIPS521 (1-30 μg in 10 μL; intrathecal administration) reduces eEPSCs in spinal cord from nerve-injured rats, with a pEC₅₀ of 6.9. The maximum MIPS521-induced decrease in synaptic current amplitude is significantly greater in nerve-injured rats than in sham surgery controls.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male and female Sprague-Dawley rats (7-12 weeks) were performed a partial nerve ligation (PNL) or sham surgery
Dosage:	1, 3, 10, 30 μg in 10 μL
Administration:	Intrathecal administration
Result:	Reduced eEPSCs in spinal cord from nerve-injured rats and reversed mechanical hyperalgesia.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male and female Sprague-Dawley rats (7-12 weeks) were performed a partial nerve ligation (PNL) or sham surgery
Dosage:	1, 3, 10, 30 μg in 10 μL
Administration:	Intrathecal administration
Result:	Reduced eEPSCs in spinal cord from nerve-injured rats and reversed mechanical hyperalgesia.

性状

Solid

溶解性数据

In Vitro:

DMSO : 25 mg/mL (55.58 mM; ultrasonic and warming and heat to 60°C)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	2.2232 mL	11.1161 mL	22.2321 mL
5 mM	0.4446 mL	2.2232 mL	4.4464 mL
10 mM	0.2223 mL	1.1116 mL	2.2232 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式